Status:
UNKNOWN
Effect of Ketamine (Ketalar) on Intracranial Pressure
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Traumatic Brain Injury
Intracranial Hypertension
Eligibility:
All Genders
Phase:
NA
Brief Summary
Objectives: Ketamine is an effective, short-acting anesthetic drug, which does not decrease blood pressure. It is widely stated that Ketamine increases intracranial pressure (ICP), which prevents its ...
Detailed Description
Objectives: Ketamine is an effective, safe, rapid, short-acting anesthetic drug, and - contrary to all other anesthetic drugs - it does not decrease blood pressure. It is widely believed that Ketamine...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children who have an ICP monitoring device, who either have increased ICP and/or who should undergo a potentially distressing activity (suction, position change etc.).
Exclusion
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00437814
Start Date
September 1 2005
End Date
February 1 2007
Last Update
February 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric ICU, Rambam Medical Center
Haifa, Israel, 31096